AC Immune to host Parkinson’s disease precision prevention symposium and present TDP-43 PET-tracer data at AD/PD 2026

Reuters03-05
AC Immune to host Parkinson’s disease precision prevention symposium and present TDP-43 PET-tracer data at AD/PD 2026

AC Immune SA will host an industry symposium, “From Treatment to Prevention in Parkinson’s Disease,” at AD/PD 2026 in Copenhagen on March 18, 2026 (8:40–10:40 am CET, Hall A1), and will also deliver an oral presentation on its first-in-class TDP-43 PET tracer [18F]ACI-19626 on March 19, 2026 (4:50–5:05 pm CET, Hall 180–181). A replay of the symposium will be available afterward on AC Immune’s Events page: https://www.globenewswire.com/Tracker?data=zmTZI76R9lh9X9YkUR-HEfMrLHI0pA9ObSK32Vo0MmETe95X13pi_AZB7Q6qOVfWpFezQFad0VOGx7NXtAXsADXE9qiseajRL-fnVb-hk8katTGUkMRMFPL_zM7ABpdo

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AC Immune Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603050700OMX_____CNEWS_EN_GNW1001168244_en) on March 05, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment